Lixte Biotechnology: Agreement Ends July 31; Company Intends to Name a New Chief Medical Officer Effective Aug. 1
Lixte Biotechnology: Agreement Ends July 31; Company Intends to Name a New Chief Medical Officer Effective Aug. 1
Lixte Biotechnology:協議將於7月31日結束;公司打算任命新的首席醫療官,自8月1日起生效
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊